Goldman Sachs’s SANUWAVE Health Inc SNWV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$404K Buy
40,426
+1,921
+5% +$29.8K ﹤0.01% 5834
2026
Q1
$666K Buy
38,505
+1,055
+3% +$26K ﹤0.01% 5393
2025
Q4
$1.12M Sell
37,450
-32,340
-46% -$1.04M ﹤0.01% 5061
2025
Q3
$2.62M Buy
+69,790
New +$2.58M ﹤0.01% 4247
2025
Q2
Sell
-9,539
Closed -$337K 6556
2025
Q1
$337K Buy
+9,539
New +$313K ﹤0.01% 5403

Other funds holding SNWV

Goldman Sachs's SNWV Position: Q2 2026 in Review

Goldman Sachs increased its SANUWAVE Health Inc (SNWV) stake by 5% in Q2 2026, buying an estimated $29.8K and bringing the position to 40,426 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #5834.

Goldman Sachs first reported a position in SNWV in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.62M in Q3 2025. 49 funds tracked by Wall St. Rank hold SNWV as of Q2 2026.

  • Goldman Sachs held 40,426 shares of SANUWAVE Health Inc worth $404K as of Q2 2026.
  • Goldman Sachs bought 1,921 SANUWAVE Health Inc shares in Q2 2026, an estimated $29.8K.
  • SANUWAVE Health Inc made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5834 holding.
  • Goldman Sachs first reported a position in SANUWAVE Health Inc in Q1 2025 and has held it in 5 quarters since.
  • Goldman Sachs's SANUWAVE Health Inc position peaked at $2.62M in Q3 2025.
  • 49 funds tracked by Wall St. Rank held SANUWAVE Health Inc as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.